Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:acquisition |
Aesthetic Medical International Holdings Limited
|
| gptkbp:ceo |
David Moatazedi
|
| gptkbp:employees |
100-200
|
| gptkbp:founded |
gptkb:2012
|
| gptkbp:founder |
David Moatazedi
|
| gptkbp:headquarters |
gptkb:Newport_Beach,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Evolus
|
| gptkbp:industry |
Aesthetic Medicine
|
| gptkbp:mission |
To deliver innovative aesthetic products.
|
| gptkbp:partnership |
Various aesthetic clinics
|
| gptkbp:product |
gptkb:Jeuveau
|
| gptkbp:products |
gptkb:botulism
|
| gptkbp:revenue |
$50 million (2020)
|
| gptkbp:target_market |
Aesthetic Practitioners
|
| gptkbp:traded_on |
gptkb:NASDAQ
|
| gptkbp:vision |
To be the leading provider of aesthetic solutions.
|
| gptkbp:website |
www.evolus.com
|
| gptkbp:bfsParent |
gptkb:Jeuveau
|
| gptkbp:bfsLayer |
7
|